Skip to main content

Bailard, Inc.

SEC CIK
0000750641
Latest filing
Jul 30, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
3,725
Value
$1.44M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by Bailard, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,725$1.44M<0.1%−826−18.1%ReducedHolders
Q1 20264,551$1.33M<0.1%−166−3.5%ReducedHolders
Q4 20254,717$1.65M<0.1%+632+15.5%AddedHolders
Q3 20254,085$1.32M<0.1%+871+27.1%AddedHolders
Q2 20253,214$1.25M<0.1%+1,421+79.3%AddedHolders
Q1 20251,793$779.9K<0.1%+116+6.9%AddedHolders
Q4 20241,677$618.6K<0.1%−4,609−73.3%ReducedHolders
Q3 20246,286$3.27M0.1%+129+2.1%AddedHolders
Q2 20246,157$3.34M0.1%−95−1.5%ReducedHolders
Q1 20246,252$3.24M0.1%−488−7.2%ReducedHolders
Q4 20236,740$3.18M0.1%+173+2.6%AddedHolders
Q3 20236,567$2.86M0.1%−10−0.2%ReducedHolders
Q2 20236,577$2.92M0.1%−4,956−43.0%ReducedHolders
Q1 202311,533$5.30M0.2%+20+0.2%AddedHolders
Q4 202211,513$5.91M0.2%−122−1.0%ReducedHolders
Q3 202211,635$5.29M0.2%+1,080+10.2%AddedHolders
Q2 202210,555$5.09M0.2%−309−2.8%ReducedHolders
Q1 202210,864$5.34M0.2%+36+0.3%AddedHolders
Q4 202110,828$5.02M0.2%00.0%UnchangedHolders
Q3 202110,828$4.04M0.1%+54+0.5%AddedHolders
Q2 202110,774$4.11M0.1%−1,155−9.7%ReducedHolders
Q1 202111,929$4.28M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.